Society guideline links: Acute promyelocytic leukemia

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Acute myeloid leukemia" and "Society guideline links: Chronic myeloid leukemia".)

Canada

●A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults (2014)

United States

●National Cancer Institute (NCI): Acute myeloid leukemia treatment – Health professional version

●NCI: Childhood acute myeloid leukemia treatment – Health professional version

●NCI: Childhood acute promyelocytic leukemia treatment – Health professional version

●College of American Pathologists (CAP) and American Society of Hematology (ASH): Guideline for the initial diagnostic workup of acute leukemia (2017)

Europe

●European Society for Medical Oncology (ESMO): Acute myeloid leukaemia in adult patients – Clinical practice guidelines for diagnosis, treatment, and follow-up (2020)

●European LeukemiaNet (ELN): Management of acute promyelocytic leukemia – Updated recommendations from an expert panel (2019)

Japan

●Japanese Society for Hematology (JSH): Practical guidelines for hematological malignancies – Leukemia-2: Acute promyelocytic leukemia (APL), 2023 (published 2024)